K

Karo Healthcare

Sells branded medicines and self-care products

Senior Global CMC Manager - Development & Lifecycle

Full-TimeUpdated on 10/15/2026
No salary listed
Senior
Bachelor's
Stockholm, Sweden
HybridHybrid model with the primary workplace in the office.
Biology & BiotechRegulatory & Quality (Life Sciences)

About the job

Requirements
  • A university degree in Life Sciences.
  • Strong understanding of regulatory requirements and applicable legal frameworks for pharmaceutical products.
  • Proven CMC expertise covering the full product lifecycle, including post-approval development and manufacturing-related changes.
  • Extensive experience in variation management, including the development and execution of regulatory and CMC strategies.
  • Experience with EU regulatory procedures, primarily national procedures as well as DCP and MRP; exposure to additional markets is an advantage.
  • Demonstrated experience working at the interface between Regulatory CMC, R&D CMC, and Manufacturing for commercialised pharmaceutical products.
  • Hands-on experience with CMC Module 3 authoring, review, and lifecycle maintenance.
  • Solid understanding of pharmaceutical manufacturing processes, formulation principles, APIs, and CMO-based supply models.
  • Proven ability to work cross-functionally with Regulatory Affairs, Quality, Manufacturing, Supply Chain, Commercial functions, and external partners.
  • Experience interacting with regulatory authorities and maintaining effective professional relationships.
  • Familiarity with relevant regulatory databases and compendial information sources.
  • Fluency in English.
Responsibilities
  • Act as global CMC Module 3 owner throughout the product lifecycle, ensuring scientific consistency and alignment with actual manufacturing processes, formulation, APIs, control strategies, and implemented post-approval changes.
  • Manage and maintain CMC Module 3 components of global and local dossiers, including technical preparation and compilation of documentation to support regulatory submissions and lifecycle maintenance, with particular responsibility for legacy products.
  • Ensure timely implementation of approved CMC changes within the defined scope, including verifying that Module 3 documentation and internal systems reflect Health Authority approvals.
  • Assess and lead regulatory CMC evaluation of proposed changes, including technical impact assessment, variation classification, and identification of required documentation in alignment with applicable EU and relevant market requirements.
  • Review and approve regulatory CMC documentation for submissions and lifecycle changes in compliance with applicable regulatory requirements and internal regulatory information and document management systems.
  • Initiate and maintain CMC-related regulatory events and documentation within the regulatory information management system, such as Veeva RIM, in accordance with internal procedures.
  • Maintain a current understanding of relevant CMC-related regulations, guidelines, and standards, as well as established and emerging manufacturing and development practices applicable to commercialised pharmaceutical products.
  • Lead CMC strategy development for assigned products across development and lifecycle phases, providing aligned CMC input to regulatory strategy discussions, technical risk assessments, gap analyses, and evaluation and implementation of lifecycle changes.
  • Apply in-depth knowledge of CMC Module 3 as a practical lifecycle tool to support and drive technical and regulatory decision-making related to manufacturing and post-approval development activities.
  • Act as a technical and regulatory CMC counterpart to manufacturing CMOs, developing a sound understanding of their manufacturing operations and providing appropriate scientific input, guidance, and challenge as required.
  • Provide CMC oversight and regulatory alignment during process validation, scale-up, and technology transfer activities to ensure a smooth transition from development to commercial manufacturing.
  • Coordinate activities with subsidiaries, external partners, and consultants across relevant markets to support aligned execution of CMC lifecycle, manufacturing, and regulatory objectives.
  • Lead preparation of CMC responses to Health Authority questions in collaboration with internal stakeholders and CMOs.
  • Serve as Regulatory CMC lifecycle project lead when appropriate, including identifying and managing technical and regulatory risks, prioritising activities, and tracking key milestones.
  • Proactively identify and mitigate technical and regulatory CMC risks to prevent approval delays, compliance exposure, or supply disruptions.
  • Define CMC documentation requirements and timelines for variations and lifecycle changes, and align with Regulatory Operations during submission planning and kick-off activities.
  • Contribute to the development, maintenance, and continuous improvement of SOPs, work instructions, and related processes supporting CMC lifecycle, manufacturing, and regulatory activities.
Desired Qualifications
  • Exposure to additional markets beyond the listed EU regulatory procedures.
  • Experience with regulatory information and document management systems, such as Veeva RIM.
  • Additional languages.

About the company

Karo Healthcare develops and markets branded medicines and personal care products for everyday health needs, including skin care, foot treatments and supplements. Its portfolio combines pharmacy brands such as E45 and Lamisil with wellness products sold under Nutravita. The business earns revenue from sales of its own brands through pharmacies, retailers, online stores and healthcare distributors, while its teams manage product development and commercial execution across markets. Its medicines include over-the-counter and prescription products, alongside cosmetics and other consumer health products. Founded in 1987, Karo Healthcare is headquartered in Stockholm, Sweden.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

1987

Get referred to Karo Healthcare

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • April 2026 added ACO, Biodermal, Emolium and Iwostin to Karo through its completed purchase from Perrigo.
  • Karo's Everything Counts Programme links employee financial rewards to company success.
  • June 2026 expanded Karo's nail fungus licensing partnership into China's cross-border ecommerce channel.

What critics are saying

  • March 2026 approval of Karo's ACO purchase required divesting Nordic Locobase rights, limiting the brands retained after consolidation.
  • Karo depends on contract manufacturers and third-party logistics providers, placing production and distribution execution with external partners.
  • Karo's Warsaw Emolium brand manager role lasts 18 months as parental leave cover.

What makes Karo Healthcare unique

  • Karo organises cross-functional squads around individual brands or categories, putting decisions with the teams managing them.
  • Karo runs Amazon and direct consumer marketing with its own account, performance marketing and creative production teams.
  • Selected Karo medicines carry Sweden's Välvald pharmacy label, requiring manufacturing-site disclosure and responsible sourcing controls.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Hybrid Work Options

Company News

Cision
Apr 15th, 2025
Karo Group Publishes The 2024 Sustainability Report

Karo Group publishes the 2024 Sustainability Report

Cision
Apr 15th, 2024
Karo Group Publishes The 2023 Sustainability Report

Karo Group publishes the 2023 Sustainability Report